224 related articles for article (PubMed ID: 29220524)
1. Brain Responses to Cigarette-Related and Emotional Images in Smokers During Smoking Cessation: No Effect of Varenicline or Bupropion on the Late Positive Potential.
Versace F; Stevens EM; Robinson JD; Cui Y; Deweese MM; Engelmann JM; Green CE; Karam-Hage M; Lam CY; Minnix JA; Wetter DW; Cinciripini PM
Nicotine Tob Res; 2019 Jan; 21(2):234-240. PubMed ID: 29220524
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological intervention and abstinence in smokers undergoing cessation treatment: A psychophysiological study.
Cui Y; Engelmann JM; Xian J; Minnix JA; Lam CY; Karam-Hage M; Cinciripini PM; Robinson JD
Int J Psychophysiol; 2018 Jan; 123():25-34. PubMed ID: 29223599
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation: Secondary Analysis of the EAGLES Randomized Clinical Trial.
Nollen NL; Ahluwalia JS; Sanderson Cox L; Okuyemi K; Lawrence D; Samuels L; Benowitz NL
JAMA Netw Open; 2021 Jan; 4(1):e2032053. PubMed ID: 33464316
[TBL] [Abstract][Full Text] [Related]
4. Mediators of the effect of nicotine pre-treatment on quitting smoking.
Hajek P; Lewis S; Munafo M; Lindson N; Coleman T; Aveyard P;
Addiction; 2018 Dec; 113(12):2280-2289. PubMed ID: 30066385
[TBL] [Abstract][Full Text] [Related]
5. Distress Tolerance and Craving for Cigarettes Among Heavy Drinking Smokers.
Lim AC; Roche DJO; Ray LA
J Stud Alcohol Drugs; 2018 Nov; 79(6):918-928. PubMed ID: 30573023
[TBL] [Abstract][Full Text] [Related]
6. Benefits of varenicline vs. bupropion for smoking cessation: a Bayesian analysis of the interaction of reward sensitivity and treatment.
Cinciripini PM; Green CE; Robinson JD; Karam-Hage M; Engelmann JM; Minnix JA; Wetter DW; Versace F
Psychopharmacology (Berl); 2017 Jun; 234(11):1769-1779. PubMed ID: 28275830
[TBL] [Abstract][Full Text] [Related]
7. The impact of three weeks of pre-quit varenicline on reinforcing value and craving for cigarettes in a laboratory choice procedure.
Lawson SC; Gass JC; Cooper RK; Tonkin SS; Colder CR; Mahoney MC; Tiffany ST; Hawk LW
Psychopharmacology (Berl); 2021 Feb; 238(2):599-609. PubMed ID: 33219852
[TBL] [Abstract][Full Text] [Related]
8. Moderators of real-world effectiveness of smoking cessation aids: a population study.
Jackson SE; Kotz D; West R; Brown J
Addiction; 2019 Sep; 114(9):1627-1638. PubMed ID: 31117151
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES.
West R; Evins AE; Benowitz NL; Russ C; McRae T; Lawrence D; St Aubin L; Krishen A; Maravic MC; Anthenelli RM
Addiction; 2018 Aug; 113(8):1507-1516. PubMed ID: 29508470
[TBL] [Abstract][Full Text] [Related]
10. Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.
Ebbert JO; Hatsukami DK; Croghan IT; Schroeder DR; Allen SS; Hays JT; Hurt RD
JAMA; 2014 Jan; 311(2):155-63. PubMed ID: 24399554
[TBL] [Abstract][Full Text] [Related]
11. Varenicline versus placebo for waterpipe smoking cessation: a double-blind randomized controlled trial.
Dogar O; Zahid R; Mansoor S; Kanaan M; Ahluwalia JS; Jawad M; Siddiqi K
Addiction; 2018 Dec; 113(12):2290-2299. PubMed ID: 30187978
[TBL] [Abstract][Full Text] [Related]
12. Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm.
Rose JE; Behm FM
Am J Psychiatry; 2014 Nov; 171(11):1199-205. PubMed ID: 24934962
[TBL] [Abstract][Full Text] [Related]
13. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.
Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo D; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
Health Technol Assess; 2021 Oct; 25(59):1-224. PubMed ID: 34668482
[TBL] [Abstract][Full Text] [Related]
14. Combination Varenicline/Bupropion Treatment Benefits Highly Dependent Smokers in an Adaptive Smoking Cessation Paradigm.
Rose JE; Behm FM
Nicotine Tob Res; 2017 Aug; 19(8):999-1002. PubMed ID: 29054128
[TBL] [Abstract][Full Text] [Related]
15. The effect of varenicline on mood and cognition in smokers with HIV.
Thompson M; Schnoll R; Serrano K; Leone F; Gross R; Collman RG; Ashare RL
Psychopharmacology (Berl); 2020 Apr; 237(4):1223-1231. PubMed ID: 31938877
[TBL] [Abstract][Full Text] [Related]
16. Modelling continuous abstinence rates over time from clinical trials of pharmacological interventions for smoking cessation.
Jackson SE; McGowan JA; Ubhi HK; Proudfoot H; Shahab L; Brown J; West R
Addiction; 2019 May; 114(5):787-797. PubMed ID: 30614586
[TBL] [Abstract][Full Text] [Related]
17. [Smoking cessation: Pharmacological strategies different from standard treatments].
Underner M; Perriot J; Peiffer G; Harika-Germaneau G; Jaafari N
Rev Pneumol Clin; 2018 Sep; 74(4):205-214. PubMed ID: 29773262
[TBL] [Abstract][Full Text] [Related]
18. Searching for Personalized Medicine for Binge Drinking Smokers: Smoking Cessation Using Varenicline, Nicotine Patch, or Combination Nicotine Replacement Therapy.
Kaye JT; Johnson AL; Baker TB; Piper ME; Cook JW
J Stud Alcohol Drugs; 2020 Jul; 81(4):426-435. PubMed ID: 32800078
[TBL] [Abstract][Full Text] [Related]
19. Predictors of long-term abstinence rate by income level in the Korean smoking cessation programme.
Seo YG; Paek YJ; Jo MW; Choi J
Addiction; 2019 Nov; 114(11):2056-2064. PubMed ID: 31261447
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy of varenicline and bupropion in smoking cessation: A meta-analysis of the randomized controlled trials.
Zhong Z; Zhao S; Zhao Y; Xia S
Compr Psychiatry; 2019 Nov; 95():152125. PubMed ID: 31669972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
